January 2014 in “Food and Drug” The method accurately detects illegal minoxidil in herbal hair products.
March 2007 in “Journal of hypertension” Minoxidil effectively lowers blood pressure in patients with resistant hypertension.
January 2007 in “Dermatologic Surgery” A new scalp surgery technique leads to significantly thinner scars.
The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.
November 2024 in “Cells Tissues Organs” Stem cells from umbilical cord blood are more effective than minoxidil for treating hair loss.
November 2024 in “Actas Dermo-Sifiliográficas” The study analyzed the effectiveness of low-dose oral minoxidil in treating frontal fibrosing alopecia (FFA) in a case series of 122 patients across centers in Brazil and Spain. Results showed that 45.1% of patients experienced improvement in the density of the frontotemporal hairline, with 34.4% showing mild, 9.0% moderate, and 1.6% excellent improvement. Additionally, 57.4% saw improved hair density in the interparietal area, 25.4% experienced eyebrow growth, and 3.3% had eyelash growth. Adverse effects were reported in 33.6% of patients, with hypertrichosis being the most common at 23.8%. The study suggests oral minoxidil as a complementary therapy for FFA, enhancing hair and eyebrow growth and frontotemporal hairline density.
October 2024 in “International Journal of Research in Medical Sciences” The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.
October 2024 in “Clinical and Experimental Dermatology” The combination treatment didn't work better than minoxidil alone and caused more menstrual issues.
October 2024 in “Actas Dermo-Sifiliográficas” Sublingual minoxidil is safe and well-tolerated for hair loss treatment.
October 2024 in “Journal of Drugs in Dermatology” Combining finasteride with minoxidil is more effective for male hair loss than using minoxidil alone.
The study compared the efficacy of intradermal botulinum toxin A (BTA) and intradermal minoxidil in treating androgenetic alopecia (AGA) in 30 patients, divided into two groups of 15 each. Both treatments were administered over three sessions, with follow-ups at 20 weeks. Results showed no statistically significant difference between the two groups in terms of total, terminal, and vellus hair counts. However, both treatments led to significant improvements in hair counts, with 53.3% of the BTA group and 66.7% of the minoxidil group showing improvement. A negative correlation was found between age and terminal hair change, and between AGA duration and total hair count change in the BTA group. Both treatments are effective and minimally invasive, but minoxidil is more cost-effective.
This study evaluated the role of sulfotransferase enzyme activity in predicting the response to minoxidil treatment in 60 male patients with androgenetic alopecia. Results showed significant increases in vellus and terminal hair counts, terminal hair percentage, total hair count, and mean hair width after 4 months of minoxidil use. Notably, patients with higher baseline sulfotransferase enzyme levels responded better to treatment, suggesting that this enzyme assay could be a valuable diagnostic tool to identify potential responders to minoxidil before starting treatment. Approximately 40% of patients experienced hair growth, highlighting the enzyme assay's potential to improve treatment outcomes by excluding non-responders.
The study investigated the effects of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) compared to conventional minoxidil treatment on androgenic alopecia (AGA) in 48 adult male albino rats. Results showed that stem cell therapy was more effective than minoxidil in treating AGA, as evidenced by changes in hair follicle dynamics, including a decrease in terminal hair number and an increase in vellus hair. Additionally, there were structural changes such as cavitations in hair and sheaths, collagen fiber deposition, and thinning of the arrector pili muscle. Overall, stem cell therapy demonstrated superior efficacy in promoting hair growth in AGA.
This study compared the efficacy and safety of topical Minoxidil 5% alone versus combined with Dutasteride (either topical 0.02% through microneedling or oral 0.5 mg) in treating androgenetic alopecia (AGA) in 30 patients (24 males, 6 females). Over 16 weeks, all groups showed significant improvement, with the combination treatments (groups B and C) yielding better results in hair density and width than Minoxidil alone (group A). Group C, using topical Dutasteride with microneedling, showed the highest improvement and fewer systemic side effects compared to oral Dutasteride. The study concluded that combining Minoxidil with topical Dutasteride via microneedling is a promising and effective treatment for AGA with minimal side effects.
September 2024 in “Journal of Clinical and Nursing Research” Combining Chuzhi Shengfa Tablets with ketoconazole shampoo or 5% minoxidil foam effectively promotes hair growth in men.
September 2024 in “Journal of Cosmetic Dermatology” Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.
September 2024 in “International Journal of Research in Dermatology” Combining PRP with minoxidil and finasteride is the most effective treatment for male hair loss.
September 2024 in “Journal of Family Medicine and Primary Care” Primary health physicians in Saudi Arabia need better guidelines for treating hair loss with vitamins and minerals.
September 2024 in “Journal of the American Academy of Dermatology” Minoxidil helps hair regrowth and has anti-aging effects on hair follicles.
August 2024 in “Pakistan Journal of Health Sciences” PRP with finasteride is better for hair regrowth than minoxidil with finasteride.
August 2024 in “Saudi Journal of Medical and Pharmaceutical Sciences” PRP combined with minoxidil is the most effective treatment for hair growth in androgenetic alopecia.
August 2024 in “Scholars Journal of Applied Medical Sciences” Combining PRP therapy with minoxidil is the most effective treatment for hair loss in men.
August 2024 in “Bioimpacts” Kopexil is an effective and safe hair growth treatment.
August 2024 in “International Journal of Biological Macromolecules” New gels using cellulose nanocrystals effectively deliver minoxidil to hair follicles, promoting hair regrowth.
July 2024 in “Quality in Sport” Combined minoxidil and PRP therapy improves hair growth without affecting physical performance.
July 2024 in “International Journal of Medical Arts” Latanoprost is more effective than minoxidil for treating alopecia areata.
July 2024 in “Journal of Dermatological Treatment” Botanical extracts and Minoxidil improved hair condition in a boy with a genetic disorder.
July 2024 in “Chemical Engineering Journal” A new microneedle system with minoxidil nanoparticles effectively promotes hair regrowth with fewer side effects.
July 2024 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil is generally safe for hypertensive patients with hair loss.
June 2024 in “Journal of Drug Delivery Science and Technology” Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.